OMRF has discovered a targeted therapy that could improve treatment and long-term outcomes for ovarian cancer.
Stephenson Cancer Center
OMRF scientists have redefined how the gut microbiome operates and how our bodies coexist with some of the 100 trillion bacteria that make it up.
The Nonagenarian Society was created by longtime OMRF board member H.E. “Gene” Rainbolt.
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
New researchers are focused on recurring breast cancer.